ATP2B4 and neoplasm: Data from the Clinical Proteomic Tumor Analysis Consortium29 (CPTAC) (https://ualcan.path.uab.edu) confirmed these findings and showed significantly reduced PMCA4 both at the mRNA (The Cancer Genome Atlas, TCGA) and protein levels in luminal breast cancer types compared to normal breast tissue.